Catalog Number ZVL14080 |
Device Problems
Premature Activation (1484); Self-Activation or Keying (1557); Failure to Advance (2524); Device-Device Incompatibility (2919); Difficult to Advance (2920)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/25/2021 |
Event Type
malfunction
|
Event Description
|
It was reported that during a stent placement procedure in the lower extremity via a femoral venipuncture to treat deep venous thrombosis, great resistance was allegedly felt when the device was advanced over the guidewire.It was further reported that device could not reach the desired location and the device was attempted to be withdrawn when the stent allegedly got deployed prematurely.The procedure was completed using another device.There was no reported patient injury.
|
|
Manufacturer Narrative
|
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.However, photos were provided for review.The investigation of the reported event is currently underway.Expiration date: 02/2024.
|
|
Manufacturer Narrative
|
H10: the file was reassessed for reportability and determined to be no longer reportable.Since an initial mdr was submitted, therefore, the file will remain assessed as a malfunction.H10: d4 (expiration date: 02/2024), g3 h11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Event Description
|
It was reported that during a stent placement procedure in the lower extremity via a femoral vein to treat deep venous thrombosis, great resistance was allegedly felt when the device was advanced over the guidewire.It was further reported that device could not reach the desired location and the device was attempted to be withdrawn when the stent allegedly got deployed prematurely.The procedure was completed using another device.There was no reported patient injury.
|
|
Event Description
|
It was reported that during a stent placement procedure in the lower extremity via a femoral vein to treat deep venous thrombosis, great resistance was allegedly felt when the device was advanced over the guidewire.It was further reported that device could not reach the desired location and the device was attempted to be withdrawn when the stent allegedly got deployed prematurely.The procedure was completed using another device.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: manufacturing review: a review of manufacturing records was not performed, as additional complaints have not been reported for this lot.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the stent delivery system was returned for evaluation and photos were equally provided.Based on the analysis of the provided photos and the returned sample, the stent was partially deployed.A device compatible guide wire could be advanced through the entire delivery system.In this case, the customer reported that the device was flushed prior to use.Based on analysis of the provided photos and returned sample, the investigation is confirmed results for unintended partial deployment.The definitive root cause could not be determined based upon available information.Labeling review: in reviewing the relevant labeling, it was found that the instructions for use sufficiently address the potential risks.With regards to device warning, the instructions for use states that "visually inspect the bard e luminexx vascular stent to verify that the device has not been damaged due to shipping or improper storage".Regarding preparation of the device the instructions for use states that "prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline (.).Flushing these lumens will also facilitate stent graft deployment.Continue flushing until saline drips from the distal tip of the catheter (d) after flushing each luer port".Regarding accessories, the instructions for use states "the bard s.A.F.E.R 6f delivery system requires a minimum 8f guiding catheter or a minimum 6f introducer sheath" also "via the femoral route, insert a 0.035¿(0.89 mm) guide wire under fluoroscopic guidance through the appropriate introducer sheath or guiding catheter and pass the lesion".The packaging pictograms indicate an introducer size of 6f and a 0.035" guidewire.With regards to indications for use, the instructions for use states that the stent is to be used on femoral and iliac arteries.Based on reported information, the intended placement site for this stent was the venous system which represents off-label use.H10: d4 (expiration date: 02/2024), g3, h6(device) h11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Search Alerts/Recalls
|
|